Does Johnson & Johnson (JNJ) Pay Dividends? Dividend Analysis & Yield

Quick Answer

Yes, Johnson & Johnson (JNJ) pays a regular quarterly cash dividend. As of July 2026, the company pays a quarterly dividend of $1.34 per share, which translates to an annualized dividend payout of $5.36 per share Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026. At current trading levels, this provides a dividend yield of approximately 2.1% This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? | Nasdaq.

Johnson & Johnson is not just a dividend payer; it is a premier "Dividend King." In April 2026, the company raised its dividend by 3.1%, marking its 64th consecutive year of dividend increases Johnson & Johnson (JNJ) - Sure Dividend. Backed by a pristine AAA credit rating and robust free cash flow generation, JNJ's dividend is widely considered one of the safest and most reliable income streams in the global equity markets.

Current Stock Price & Valuation

To understand the context of Johnson & Johnson's dividend, we must look at its current market valuation as of July 2026.

The stock has experienced a significant run-up over the past year, climbing more than 60% to trade near all-time highs This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? | Nasdaq. While this capital appreciation has been excellent for total return investors, it has compressed the dividend yield down to 2.1%, which is roughly in line with the Large Cap Pharmaceuticals industry average of 2.1% but notably higher than the S&P 500's 1.38% yield Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.

Detailed Analysis

Dividend Yield and Annual Payout

Johnson & Johnson's current annualized dividend is $5.36 per share, distributed in quarterly installments of $1.34 Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026 | Johnson & Johnson. The 2.1% yield is somewhat lower than the company's historical average, primarily because the stock price has appreciated rapidly. For income-focused investors, a 2.1% yield might seem modest, but it comes with a near-guarantee of annual inflation-beating raises.

Payout Ratio and Free Cash Flow Coverage

A critical metric for dividend safety is the payout ratio. Johnson & Johnson's payout ratio currently sits at a very healthy 46% to 48% of adjusted earnings Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now. This is a significant improvement from previous years where the payout ratio temporarily spiked higher, indicating that earnings growth is comfortably outpacing dividend obligations Johnson & Johnson Stock Hits 64 Straight Years of Dividend Growth in 2026 | TIKR.com.

Furthermore, management has reaffirmed a full-year 2026 free cash flow target of approximately $21.0 billion Johnson & Johnson Stock Hits 64 Straight Years of Dividend Growth in 2026 | TIKR.com. This massive cash generation provides an enormous buffer to cover the dividend, fund research and development, and execute share repurchases.

Dividend Growth Rate

JNJ has increased its dividend for 64 consecutive years. Over the last 5 years, the company has maintained an average annual dividend growth rate of 5.37% Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now. The most recent hike in April 2026 was 3.1% Johnson & Johnson (JNJ) - Sure Dividend. Over a 10-year horizon, earnings per share have grown at an annualized rate of 6.9%, providing the fundamental fuel required to keep the dividend growing Johnson & Johnson (JNJ) - Sure Dividend.

Dividend Safety

Dividend safety for JNJ is virtually unparalleled. The company is one of only two U.S. corporations to hold a AAA credit rating from S&P—a rating higher than that of the U.S. federal government This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? | Nasdaq. With $20.4 billion in cash and cash equivalents on the balance sheet at the end of Q2 2026, the dividend is insulated against almost any macroeconomic shock Johnson & Johnson posts $25.3B Q2 2026 revenue | JNJ Quarterly Report (10-Q).

Bull Case

The bullish argument for Johnson & Johnson as a dividend investment centers on its unmatched reliability and shifting business mix. Following the spin-off of its consumer health division, JNJ is now a more focused, higher-margin business concentrated on Innovative Medicines and MedTech.

  1. Unshakable Financials: With a projected $21 billion in free cash flow for 2026 and a AAA balance sheet, JNJ can easily afford its dividend while continuing to invest heavily in R&D Johnson & Johnson Stock Hits 64 Straight Years of Dividend Growth in 2026 | TIKR.com.
  2. Consistent Growth: The company is on track to hit a historic $100 billion in annual revenue in 2026 Johnson & Johnson Stock Hits 64 Straight Years of Dividend Growth in 2026 | TIKR.com.
  3. Pipeline Success: Growing drugs like Darzalex and Tremfya are successfully offsetting revenue losses from older drugs losing exclusivity This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? | Nasdaq.

Bear Case

Despite its strengths, there are risks that income investors must consider before buying JNJ at current valuations.

  1. Valuation and Compressed Yield: Because the stock has surged over 60% in the past year, the dividend yield has dropped to 2.1% This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? | Nasdaq. Investors buying today are getting less immediate income per dollar invested than they have historically.
  2. Talc Litigation Overhang: JNJ still faces tens of thousands of lawsuits alleging its legacy talc-based baby powder caused cancer. A judge rejected a proposed $10 billion settlement, meaning this remains a lingering cash liability and headline risk This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? | Nasdaq.
  3. Patent Cliffs: The blockbuster drug Stelara is facing steep biosimilar competition, with its revenue falling roughly 60% year-over-year in early 2026 This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? | Nasdaq.

Key Metrics Summary

MetricCurrent Value (July 2026)
Stock Price~$257.00
Annual Dividend$5.36
Quarterly Dividend$1.34
Dividend Yield2.1%
Payout Ratio~46% - 48%
5-Year Div Growth Rate5.37%
Consecutive Increases64 Years
2026 Est. Free Cash Flow$21.0 Billion
Credit RatingAAA (S&P)

Frequently Asked Questions

How often does Johnson & Johnson pay dividends?

Johnson & Johnson pays dividends on a quarterly basis. Payments are typically distributed in March, June, September, and December. For example, the Q3 2026 dividend of $1.34 is payable on September 8, 2026, to shareholders of record as of August 25, 2026 Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026 | Johnson & Johnson.

Is Johnson & Johnson's dividend safe?

Yes, it is considered one of the safest dividends in the world. The company has a payout ratio of just 46%, generates over $20 billion in annual free cash flow, and holds a AAA credit rating This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? | Nasdaq.

What is a Dividend King, and is JNJ one?

A Dividend King is a company that has increased its annual base dividend for at least 50 consecutive years. Johnson & Johnson is a prominent Dividend King, having raised its payout for 64 consecutive years as of 2026 Johnson & Johnson Stock Hits 64 Straight Years of Dividend Growth in 2026 | TIKR.com.

How does JNJ's yield compare to the broader market?

At 2.1%, JNJ's dividend yield is higher than the S&P 500 average of approximately 1.38%, and it is directly in line with the Large Cap Pharmaceuticals industry average of 2.1% Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.

Final Verdict

Johnson & Johnson remains a gold-standard holding for dividend growth investors. With 64 consecutive years of dividend increases, a conservative 46% payout ratio, and a fortress AAA balance sheet, the safety and sustainability of the $5.36 annual payout are beyond reproach.

However, investors must weigh the current valuation. The stock's massive 60% run-up over the past year has compressed the yield to 2.1%. While the income stream is virtually guaranteed to grow, new capital deployed at $257 per share is buying a lower starting yield than has historically been available. For conservative investors prioritizing capital preservation and sleep-well-at-night income growth, JNJ remains a core portfolio holding. Value-conscious buyers, however, may prefer to wait for a pullback to secure a higher initial yield.

Ready to Analyze Your Next Investment?

Get a free AI-powered fair value analysis on any stock. See intrinsic value, margin of safety, and institutional-grade risk metrics in seconds. No credit card required.

Want full access to our institutional research tools? Explore Invest Daily Pro.

Put This Into Practice

You're reading about dividend safety. But is YOUR dividend actually safe?

Our AI analyzes payout ratio trends, free cash flow coverage, balance sheet risk, and dividend growth history to give every stock a Fortress Score from 0–100.

Watch: Related Videos

from Invest Daily
Watch: This Penny Stock Does $10M in Revenue… So Why Is It Valued Under $200K? (AFFU)
YouTube
Watch: I Built an AI That Values Any Stock in 30 Seconds (Full Demo)
YouTube

Get This Analysis in Your Inbox Every Morning

Get our daily market briefing with institutional-grade analysis, key developments, and actionable strategy - delivered before the opening bell.